Prokupets Elena's Form 4 filing
C4 Therapeutics, Inc.CCCC · filed Sep 14, 2021
- Accession no.
- 0001209191-21-055886
- Filed
- Sep 14, 2021
- Trade date
- Sep 10-13, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $461.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Prokupets ElenaCIK 0001824823 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2021 | Common Stock | SSaleDisposed | −1,230 | $50.00F2 | −$61,500 | 87,344 | Indirect | |
| Sep 10, 2021 | Common Stock | SSaleDisposed | −1,320 | $50.01F2 | −$66,013.2 | 591,553 | Indirect | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −3,330 | $50.07F5 | −$166,733.1 | 84,014 | Indirect | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −3,330 | $50.07F5 | −$166,733.1 | 588,223 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 2 transactions in Table I.
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.54. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 2 transactions in Table I.